🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 21 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/06/2023 28,16 28,37 27,25 27,67 -1,50% 3,98% 828.000
28/06/2023 28,29 28,57 27,60 28,09 +0,04% 3,43% 1.040.200
27/06/2023 28,94 29,25 28,01 28,08 -2,33% 4,28% 808.500
26/06/2023 28,25 28,81 27,26 28,75 +4,13% 5,49% 1.139.500
23/06/2023 27,28 27,89 26,87 27,61 +0,25% 3,74% 2.589.300
22/06/2023 27,26 28,93 27,08 27,54 +0,11% 6,79% 1.262.600
21/06/2023 26,99 27,87 26,75 27,51 +1,93% 4,15% 829.000
20/06/2023 27,82 28,69 26,96 26,99 -2,60% 6,22% 1.178.700
16/06/2023 29,08 29,08 27,24 27,71 -3,38% 6,34% 4.384.700
15/06/2023 28,49 28,93 28,12 28,68 -0,14% 2,84% 718.300
14/06/2023 29,09 29,09 28,41 28,72 -1,34% 2,33% 625.300
13/06/2023 28,91 29,35 28,74 29,11 +0,45% 2,12% 489.100
12/06/2023 29,42 30,10 28,57 28,98 -0,38% 5,20% 1.104.300
09/06/2023 29,50 29,56 28,72 29,09 -0,92% 2,85% 725.200
08/06/2023 28,83 29,42 28,40 29,36 +1,28% 3,56% 842.200
07/06/2023 28,89 29,17 27,75 28,99 +0,28% 4,92% 712.200
06/06/2023 28,85 29,30 28,43 28,91 +0,49% 3,02% 749.800
05/06/2023 28,06 29,08 28,04 28,77 +2,02% 3,71% 1.232.700
02/06/2023 27,58 28,26 27,27 28,20 +2,58% 3,59% 725.400
01/06/2023 25,85 27,97 25,71 27,49 +5,45% 8,74% 1.573.200
31/05/2023 25,43 26,14 25,06 26,07 +2,36% 4,25% 975.300
30/05/2023 26,25 27,10 25,36 25,47 -2,97% 6,63% 940.300
26/05/2023 25,29 26,45 25,21 26,25 +3,51% 4,90% 850.200
25/05/2023 26,07 26,54 25,34 25,36 +0,96% 4,60% 1.149.600
24/05/2023 25,00 25,15 24,44 25,12 -0,32% 2,84% 1.211.200
23/05/2023 25,57 25,96 25,10 25,20 -1,56% 3,36% 2.036.200
22/05/2023 26,31 26,73 25,47 25,60 -1,73% 4,79% 923.100
19/05/2023 25,49 26,50 25,30 26,05 +4,03% 4,73% 824.000
18/05/2023 26,09 26,87 24,73 25,04 -4,90% 8,20% 738.600
17/05/2023 25,54 26,36 25,19 26,33 +3,66% 4,58% 1.505.700